Equity · Healthcare
EW
NYSEEdwards Lifesciences (EW)
The line runs 90 USD on 4 August through 92.01 USD on 30 October, on a scale from 80 to 95. Days the market did not trade hold the previous close, flat.
- Market cap
- 53.0B USD
- P/E (TTM)
- 52.9
- Revenue, year to Dec 2025
- 6.1B USD
- EPS, diluted, year to Dec 2025
- 1.83 USD
- 52-week range
- 75.82 USD – 95.17 USD
- Avg volume
- 231.6K
- Mentions, 30 days
- 9
- Net sentiment
- +0.01
as of Oct 30, 2026
Have Edwards Lifesciences (EW) insiders bought or sold shares recently?
In the 90 days to 2 Nov 2026, Edwards Lifesciences insiders reported 7 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 22 Feb 2026, show no open-market purchase.
Form 4, 90 days to 2 Nov 2026, newest reported trade 8 Oct 2026
Buys 0Sells 7Net sold $3.46MOther filings 8
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 08 Oct 2026 | Lippis Daniel J.CVP, TAVR | Sell | 619 | 53K USD |
| 11 Sep 2026 | Lippis Daniel J.CVP, TAVR | Sell | 619 | 54K USD |
| 31 Aug 2026 | Dahl Andrew M.SVP, Corporate Controller | Sell | 544 | 50K USD |
| 28 Aug 2026 | Bruls AnnetteCVP, EMEACLA | Sell | 2,644 | 238K USD |
| 26 Aug 2026 | Chopra DaveenCVP, TMTT, Surgical & IHFM | Sell | 31,800 | 2.9M USD |
| 26 Aug 2026 | Markowitz WayneCVP, JAPAC | Sell | 1,240 | 113K USD |
| 11 Aug 2026 | Lippis Daniel J.CVP, TAVR | Sell | 619 | 57K USD |
| Sold | 7 open-market sales | 38,085 | $3.46M |
8 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 08 Oct 2026 | Lippis Daniel J.CVP, TAVR | Option exercise | 619 | 45K USD |
| 14 Sep 2026 | Markowitz WayneCVP, JAPAC | Tax withheld | 568 | 48K USD |
| 13 Sep 2026 | Dahl Andrew M.SVP, Corporate Controller | Tax withheld | 253 | 21K USD |
| 11 Sep 2026 | Markowitz WayneCVP, JAPAC | Tax withheld | 355 | 31K USD |
| 11 Sep 2026 | Chopra DaveenCVP, TMTT, Surgical & IHFM | Tax withheld | 398 | 35K USD |
| 11 Sep 2026 | Lippis Daniel J.CVP, TAVR | Option exercise | 619 | 45K USD |
| 26 Aug 2026 | Chopra DaveenCVP, TMTT, Surgical & IHFM | Option exercise | 31,800 | 2.3M USD |
| 11 Aug 2026 | Lippis Daniel J.CVP, TAVR | Option exercise | 619 | 45K USD |
Which funds hold Edwards Lifesciences (EW)?
11 of the 45 institutional funds we track reported a Edwards Lifesciences position for the quarter ended 30 Jun 2026 — a combined 1.3B USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Citadel Advisors | Added | 3,997,925 | 361.7M USD | +670.3% |
| Millennium Management | Added | 3,584,795 | 324.3M USD | +99.5% |
| Point72 Asset Management | Held (±25%) | 1,774,120 | 160.5M USD | −2.9% |
| Two Sigma Investments | Added | 1,521,899 | 137.7M USD | +44.7% |
| AQR Capital Management | Trimmed | 1,465,185 | 132.2M USD | −25.6% |
| Man Group | Held (±25%) | 935,186 | 84.6M USD | −18.5% |
| Balyasny Asset Management | Added | 456,202 | 41.3M USD | +4,462.9% |
| Marshall Wace | Trimmed | 344,361 | 31.2M USD | −82.8% |
| Bridgewater Associates | Added | 275,279 | 24.9M USD | +60.1% |
| Fisher Asset Management | Trimmed | 87,769 | 7.9M USD | −33.6% |
Showing the 10 largest of 11 reported positions. The figures above count all of them.
Have members of Congress traded Edwards Lifesciences (EW)?
The most recent congressional trade disclosed in Edwards Lifesciences is a sale by Josh Gottheimer (house, NJ), dated 19 Nov 2025.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 19 Nov 2025 | Josh Gottheimerhouse · Democrat–NJ | Sale | 1K USD–15K USD | 40 days |
| 21 Apr 2025 | Bruce Westermanhouse · Republican–AR | Sale | 1K USD–15K USD | 21 days |
| 08 Apr 2025 | Robert P. Bresnahan, Jr.house · Republican–PA | Purchase | 1K USD–15K USD | 30 days |
| 03 Mar 2025 | Bruce Westermanhouse · Republican–AR | Purchase | 1K USD–15K USD | 44 days |
| 11 Apr 2024 | Mike Kellyhouse · Republican–PA | Sale | 1K USD–15K USD | 64 days |
| 11 Dec 2023 | Josh Gottheimerhouse · Democrat–NJ | Purchase | 1K USD–15K USD | 27 days |
| 04 Dec 2023 | John R. Curtissenate · Republican–UT | Sale | 1K USD–15K USD | 11 days |
| 21 Jun 2023 | John R. Curtissenate · Republican–UT | Purchase | 1K USD–15K USD | 47 days |
What has been filed or recorded for Edwards Lifesciences (EW)?
The filings we hold for Edwards Lifesciences, newest first: 11 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 18 shares | 2K USD notional · <0.001% of shares out |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 47 shares | 4K USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 47 shares | 4K USD notional · <0.001% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 47 shares | 4K USD notional · <0.001% of shares out |
| 07 Oct 2026 | Fails to deliver | Shares failed to deliver | 47 shares | 4K USD notional · <0.001% of shares out |
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 47 shares | 4K USD notional · <0.001% of shares out |
| 02 Oct 2026 | Fails to deliver | Shares failed to deliver | 100 shares | 9K USD notional · <0.001% of shares out |
| 01 Oct 2026 | Fails to deliver | Shares failed to deliver | 50 shares | 4K USD notional · <0.001% of shares out |
| 30 Sep 2026 | Fails to deliver | Shares failed to deliver | 74 shares | 7K USD notional · <0.001% of shares out |
| 24 Sep 2026 | Fails to deliver | Shares failed to deliver | 32 shares | 3K USD notional · <0.001% of shares out |
| 21 Sep 2026 | Fails to deliver | Shares failed to deliver | 4,800 shares | 424K USD notional · 0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 0.42 USD | Revenue $1.74B |
| 30 Jun 2026 | Financials | Total assets | 13.9B USD | at period end |
| 30 Jun 2026 | Financials | Total equity | 10.6B USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 0.66 USD | Revenue $1.65B |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 1.83 USD | Revenue $6.07B |
| 31 Dec 2025 | Financials | Revenue | 6.1B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 1.1B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 1.83 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.50 USD | Revenue $1.55B |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.56 USD | Revenue $1.53B |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.61 USD | Revenue $1.41B |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 0.65 USD | Revenue $1.39B |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS 5.13 USD | Revenue $1.35B |
What is Reddit saying about Edwards Lifesciences (EW)?
Reddit mentioned EW 9 times in the 30 days to 2 November 2026, across 4 of the communities we track. All of them were scored for sentiment: 67% read bullish, 22% bearish and 11% neither. Reddit data updated 2 November 2026.
30-day window, Method
Mentions, 30 days 9Bullish 67%Bearish 22%Communities 4Against the market +13 points
How do Reddit mentions of Edwards Lifesciences (EW) compare with its price?
Share ↗
Where Edwards Lifesciences (EW) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 50% | 5 | −0.09 |
| r/etfs | 30% | 3 | +0.14 |
| r/options | 10% | 1 | +0.00 |
| r/stocks | 10% | 1 | +0.12 |
Moves with Edwards Lifesciences (EW)
Tickers whose daily Reddit volume rose and fell with Edwards Lifesciences (EW)'s. Co-discussion, not price.
SPR +0.55TRADE WAR +0.51GASOLINE +0.50FLNT +0.49RAVE +0.49HAL +0.49
How closely daily Reddit mention counts rose and fell together over the last 30 days (31 daily observations), Method
Edwards Lifesciences (EW): frequently asked questions
What did Edwards Lifesciences shares close at?
Edwards Lifesciences closed at 92.01 USD on 30 Oct 2026, down 2.57% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Edwards Lifesciences’ market cap?
Edwards Lifesciences is worth 53.0B USD by market value as of 30 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is Edwards Lifesciences’ P/E ratio?
Edwards Lifesciences has a price-to-earnings ratio of 52.9, as of 30 Oct 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Edwards Lifesciences’ revenue?
Edwards Lifesciences reported revenue of 6.1B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Edwards Lifesciences insiders bought or sold shares recently?
In the 90 days to 2 Nov 2026, Edwards Lifesciences insiders reported 7 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 22 Feb 2026, show no open-market purchase. A further 8 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Edwards Lifesciences?
11 of the 45 funds we track reported a Edwards Lifesciences position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Citadel Advisors, Millennium Management and Point72 Asset Management. See Funds
Have members of Congress traded Edwards Lifesciences?
Yes. 17 trades in Edwards Lifesciences appear in the congressional disclosures we hold; the latest is a sale by Josh Gottheimer (House, NJ) dated 19 Nov 2025, filed 29 Dec 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Edwards Lifesciences last report earnings?
Edwards Lifesciences last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of 0.42 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Edwards Lifesciences?
Edwards Lifesciences was mentioned 2 times in the last 7 days across the finance subreddits we track, and 9 times over the trailing 30 days. Of the 9 mentions scored for sentiment, 67% read bullish and 22% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings